FDA Staff Questions Heart Risks of Merck's Arcoxia (Reuters


Reuters - Merck & Co. Inc.'s painkiller
Arcoxia offers a "marginal" advantage in gastrointestinal
safety but seems "worse than" other pain drugs in terms of
deaths and serious cardiovascular problems, U.S. regulatory
staff said in documents released on Friday.

Read more...